Pennside Partners Welcomes New European Director

Posted by Tom Penrice on Mon,Feb 20, 2017 @ 06:34 PM

Tom Perkins joins Pennside Partners, a pharma and biotech consulting firim, as European Director.Pennside Partners extends a warm welcome to Tom Perkins, who has been hired as a Director based out of our Zurich office. Tom brings 14 years of pharmaceutical consulting experience to Pennside. Tom is joining Pennside after more than a decade with leading market research firm, GfK. He began his pharma career first as an intern at V2 (acquired by GfK) during his studies at St. Joseph’s University (Philadelphia, PA, United States). He then quickly advanced through the organization to become a Division Manager of GfK’s Swiss arm based in Basel, Switzerland where he was the key account manager for one of GfK’s top clients.


Tom brings vast expertise in respiratory conditions (COPD, PAH, Cystic Fibrosis) and previous experience in oncology and hematology. In his last 3 years with GfK, Tom was running launch tracking for a major respiratory player. Previously, he was the project leader for the largest primary market research program ever conducted in Type 2 Diabetes where over 6,000 physicians and 10,000 patients from 26 countries gave insights on physician communication and marketing. Publications regarding this Diabetes project are forthcoming in 2017.


“We are excited to have Tom join our team. He will be an integral part of our plans to expand our European presence while continuing to provide excellent service to our existing client base. Our recent staff additions as well as the opening of our Manchester, UK area office in May of 2016 demonstrate our commitment to delivering the highest quality business development support, strategy, and competitive intelligence services to the pharmaceutical and biotech industries on a global scale,” said Tom Penrice, VP and Co-Founder of Pennside Partners.

For more information, including how Pennside can help you with your business development and competitive intelligence needs, contact Pennside Partners at 610-372-7000 or consult@pennside.com.

Pennside Partners EU Headquaters in Zurich, Switzerland, from which Pennside's new European Director will serve Pennside's pharmaceutical and biotech clients.Pennside’s Zurich office is located at Balsberg, Balz Zimmermann Strasse 7, CH-8058 Zurich-Flughafen, Switzerland and can be reached at +41 79 372 7070. You may also visit the company website: www.pennside.com.


About Pennside Partners

Pennside Partners is a leading business development consulting firm that has been serving the global pharmaceutical, biotechnology, and medical device sectors for more than 25 years. We earn our clients’ trust by consistently delivering high quality, actionable business insights and competitive intelligence. Our clients gain significant competitive advantages, including knowledge we acquire from mining the industry's deepest analog repository containing unmatched data insights into major launches. We offer an expert worldwide team of industry professionals who support our clients by formulating best-in-class tactical and strategic analysis. 


Pennside Partners is a leading pharmaceutical and biotech consulting firm with over 25 years experience. They have offices in the United States, United Kingdom, and Switzerland.

Tags: Pharma Consulting, Biotech Consulting

Receive Blog Posts by Email

Follow Us

Learn More About Our Services

Learn more about Pennside's pharma war games, strategy workshops, and competitive simulations for the pharma and biotech industries


Learn more about Pennside's pharma launch analog services, including pharma business development, pharma benchmarking, pharma best practices, pharma business analytics, business intelligence, ci, competitive intelligence, pharma launch planning, and other strategic consulting services for the pharmaceutical industry. 

Learn more about Pennside's  pharmaceutical and biotechnology consulting services spanning the following areas: competitive intelligence and monitoring, pipeline analysis and disease landscape consulting, marketing/sales/reimbursement support benchmarking, launch support and best practices benchmarking, customer facing and new commercial models, licensing and support consulting, strategy workshops, and outsourced business intelligence and fixed term contractors consulting for the pharma and biotech industries. 

Learn more about Pennside's Robust Pharma Competitive Intelligence and CI Monitoring Services. We provide superior pharma strategies based on actionable corporate intelligence. 

Learn more about our Oncology Drug Development Support Services: oncology launch analog service, oncology congress coverage service, post-launch intelligence and market monitoring, oncology business development and licensing and M&A support, and tumor/MOA clinical pipeline analysis services. Oncology launch adoption and market strategy services include: launch planning support, primary field intelligence and market insights, oncology competitive pipeline analysis, inlicensing reviews, oncology biomarker analysis, and benchmarking of oncology organizations. Oncology Congress Coverage services include: preparing a targeted congress schedule, attending and capturing key oncology conference information, and presenting oncology conference findings.

Contact Us or Request Information

Experience You Can Trust

Trusted pharma and biotech consulting experts for over 25 years